Mosaic ImmunoEngineering Inc.SEC Filings
|
|
All SEC filings by Mosaic ImmunoEngineering Inc. (CPMV) — annual and quarterly reports, current reports, registrations, proxies and ownership forms, updated in real time.
Financials
| 10-Q | Quarterly report | View Diff | Aug 14, 2026 | |
| 10-Q | Quarterly report | View Diff | May 20, 2026 | |
| NT 10-Q | Notice of late quarterly filing | May 15, 2026 | ||
| 10-K | Annual report | View Diff | Apr 15, 2026 | |
| NT 10-K | Notice of late annual filing | Mar 31, 2026 | ||
| 10-Q | Quarterly report | View Diff | Nov 19, 2025 | |
| NT 10-Q | Notice of late quarterly filing | Nov 12, 2025 | ||
| 10-Q | Quarterly report | View Diff | Aug 19, 2025 | |
| NT 10-Q | Notice of late quarterly filing | Aug 12, 2025 | ||
| 10-Q | Quarterly report | View Diff | May 20, 2025 |
Events
| 8-K | Other Events | Jan 2, 2025 | ||
| 8-K | Departure of Directors or Certain Officers | Jul 25, 2024 | ||
| 8-K | Departure of Directors or Certain Officers | May 31, 2024 | ||
| 8-K | Changes in Registrant'S Certifying Accountant | May 21, 2024 | ||
| 8-K | Regulation Fd Disclosure | Apr 29, 2024 | ||
| 8-K | Departure of Directors or Certain Officers | Apr 19, 2024 | ||
| 8-K | Entry Into a Material Definitive Agreement | Mar 28, 2024 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jun 26, 2023 | ||
| 8-K | Departure of Directors or Certain Officers | May 3, 2023 | ||
| 8-K | Entry Into a Material Definitive Agreement | Jul 12, 2022 |
Registrations and Prospectuses
| RW | Registration withdrawal request | Dec 28, 2022 | ||
| S-1 | IPO registration | Feb 4, 2022 | ||
| S-8 | Registration of securities for employees | Mar 9, 2021 | ||
| S-3/A | Shelf registration | View Diff | Jan 21, 2021 | |
| S-3 | Shelf registration | Dec 10, 2020 | ||
| D | $3.75k in Options / Securities to Be Acquired, Sold $3.75k, 1 Investor | Jan 26, 2010 | ||
| S-8 | Registration of securities for employees | Apr 2, 2009 | ||
| S-8 | Registration of securities for employees | Mar 28, 2008 | ||
| POS AM | Prospectus update (post-effective amendment) | Dec 26, 2007 | ||
| SB-2/A | Registration of securities for small business issuer | Apr 2, 2007 |
Proxies
| DEF 14C | Information statement | Jun 25, 2021 | ||
| PRE 14C | Preliminary information | Jun 15, 2021 | ||
| DEF 14C | Information statement | Nov 2, 2020 | ||
| PRE 14C | Preliminary information | Oct 23, 2020 | ||
| DEF 14A | Definitive proxy | View Diff | Apr 18, 2018 | |
| DEFA14A | Additional proxy soliciting materials | Apr 18, 2018 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 15, 2017 | |
| DEF 14A | Definitive proxy | View Diff | Mar 18, 2016 | |
| PRE 14A | Preliminary proxy | Mar 8, 2016 | ||
| DEF 14A | Definitive proxy | View Diff | Mar 9, 2015 |
Other
| EFFECT | Notice of effectiveness | Feb 1, 2021 | ||
| CORRESP | Correspondence with SEC | Jan 25, 2021 | ||
| CORRESP | Correspondence with SEC | Jan 21, 2021 | ||
| UPLOAD | Letter from SEC | Dec 21, 2020 | ||
| CT ORDER | Confidential treatment order | Sep 26, 2016 | ||
| CT ORDER | Confidential treatment order | Jan 5, 2015 | ||
| CT ORDER | Confidential treatment order | Sep 16, 2014 | ||
| CT ORDER | Confidential treatment order | Feb 14, 2013 | ||
| NO ACT | No action letter | Oct 18, 2010 | ||
| NO ACT | No action letter | Sep 29, 2010 |
Ownership
| 4 | Steven W King | Feb 22, 2022 | ||
| 4 | Gloria Felcyn | Feb 22, 2022 | ||
| 4 | Robert L Garnick | Feb 22, 2022 | ||
| 4 | Robert Baffi | Feb 22, 2022 | ||
| 4 | Nicole Franziska Steinmetz | Feb 22, 2022 | ||
| 3 | Robert Baffi | Jul 16, 2021 | ||
| 4 | Robert L Garnick | May 10, 2021 | ||
| 4 | Gloria Felcyn | May 10, 2021 | ||
| 4 | Nicole Franziska Steinmetz | Apr 30, 2021 | ||
| 4 | Nicole Franziska Steinmetz | Jan 29, 2021 |